Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation.
TAN WF, Qiu ZQ, YU Y, RAN RZ, YI B, LAU WY, LIU C, QIU YH, FENG FL, WANG JH, YAN PN, ZHANG BH, WU MC, LUO XJ, JIANG XQ.
TAN WF, et al. Among authors: jiang xq.
Acta Pharmacol Sin. 2010 Dec;31(12):1643-8. doi: 10.1038/aps.2010.124. Epub 2010 Nov 22.
Acta Pharmacol Sin. 2010.
PMID: 21102481
Free PMC article.